PMA device
Reflection Ceramic Acetabular Hip System (Rchs)
Smith & Nephew, Inc. · Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented (MRA, Class III) · First FDA decision Feb 18, 2009, newest Mar 20, 2018Hip osteoarthritis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
89
Naming "Reflection"
MAUDE reports
221
Brand "Reflection", since 2015
PubMed studies
88,322
Mentioning "Reflection"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Reflection Ceramic Acetabular Hip System (Rchs)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- REFLECTION CERAMIC ACETABULAR HIP SYSTEM (RCHS)PMA supplement
P030022-S039 · Decided Mar 20, 2018 · 547 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented (MRA) · Orthopedic Surgery
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Heavy Metal TestingLocal determinationIn effectL35074Wellpoint FederalUpdated Jul 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Reflection", any status and sponsor, newest update first.
- Comparison of Breast Acoustic CT and Automated Breast Ultrasound in Women With Unilateral Untreated Breast CancerNot yet recruiting
Stanford UniversityAcademic, hospital or other
NCT07946224 · 40 participants (planned) · Start Jan 2027 · Primary completion Jan 2029
Device: QT Scanner: Quantitative Transmission Ultrasound Breast Imaging System; ABUS: Invenia™ ABUS, Invenia Automated Breast Ultrasound System, ABUS, GE ABUS · For: Breast Cancer
Sites: Palo Alto, California
88 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Reflection", and for the whole product code for context.
This brand
221 reports: 25 malfunction, 196 injury, 0 death
Whole product code MRA
3,565 reports: 1,861 malfunction, 1,695 injury, 9 death
Newest reports for this brand
- REFLECTION LINER REMOVAL TOOLMalfunction
1020279-2026-01091 · Received Aug 8, 2026 · Event dated Jul 13, 2026
Device type: Prosthesis, Hip, Femoral Component, Cemented, Metal (JDG)
Device problem as coded: Fracture
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2053-2011 · Started Mar 11, 2011 · Posted by FDA Apr 22, 2011
Reason given: During the manufacturing process for several batches of R3 Ceramic Liners, the titanium rings were pressed onto the ceramic component with a higher force than allowed by manufacturing specifications. This has the potential to result in lower than expected strength for the liners.
Cause as FDA categorized it: Employee error · Device type: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented (MRA)
5 more recall records with a free account
Published research
The most relevant PubMed records for "Reflection"[tiab]. The summary above synthesizes these.
- Reflection: a review of the literature.
Atkins S, Murphy K · J Adv Nurs · 1993Review
- The use of reflection in medical education: AMEE Guide No. 44.
Sandars J · Med Teach · 2009
- Using reflection in nursing practice to enhance patient care.
Lucas B · Nurs Stand · 2023
- Understanding reflective practice.
Nicol JS, Dosser I · Nurs Stand · 2016
- "Existential Fridays"-reflection in action.
Shand JC · Pediatr Blood Cancer · 2018
- Conflict, candour and reflection.
Beattie RM · Arch Dis Child · 2019Editorial, Comment
- Reflection in Rural Family Medicine Education.
Ohta R, Sano C · Int J Environ Res Public Health · 2022
- What is reflection? A conceptual analysis of major definitions and a proposal of a five-component model.
Nguyen QD, Fernandez N, Karsenti T, et al. · Med Educ · 2014
- Reflection Of Reflections: Building Diagnostic Expertise.
Shimizu T · Int J Gen Med · 2019
- A virtuous framework for professional reflection.
George AJ, Urch CE, Cribb A · Future Healthc J · 2023
- Improving nurses' level of reflection.
Price B · Nurs Stand · 2017
- Teaching critical reflection in health professions education with transformative-vygotskian praxis.
Diaz BA, Rieker J, Ng S · Adv Health Sci Educ Theory Pract · 2023
Other devices of this type
Also filed under product code MRA.
- Ceramax® Ceramic Total Hip SystemDePuy Orthopaedics, Inc. · PMA 2025
- R3 Delta Ceramic Hip SystemSmith & Nephew, Inc. · PMA 2025
- Duraloc Option Ceramic Hip SystemDePuy Orthopaedics, Inc. · PMA 2012
- DePuy Ceramax Ceramic Total Hip SystemDePuy Orthopaedics, Inc. · PMA 2025
- Novation Ceramic Articulation Hip SystemExactech, Inc. · PMA 2017
- Trilogy Ab Acetabular SystemZimmer, Inc. · PMA 2011
- Ceramic Transcend® Hip Articulation SystemMicroport Orthopedics, Inc. · PMA 2018
- Ceramic Transcend Hip Articulation SystemCeramtec GmbH · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.